Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation

The Journal of Headache and Pain

Consensus Article

Rigmor Højland Jensen¹  Lars Bendtsen¹  Andrea Negro²  Paolo Martelletti³  Zaza Katsarava⁴  Delphine Magis⁵  Dimos-Dimitrios D Mitsikostas⁶  Michael Bjørn Russell⁷  Christian Lampl⁸ 

[1] Danish Headache Center, Department of Neurology, University of Copenhagen, Glostrup Hospital, Copenhagen, Denmark;Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy;Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy;Regional Referral Headache Centre, Sant’Andrea Hospital, Rome, Italy;Department of Neurology, Evangelical Hospital, Unna, Germany;Department of Neurology, University of Duisburg-Essen, Essen, Germany;Department of Neurology, Headache Research Unit, University of Liège, Liège, Belgium;Department of Neurology, Naval Hospital, Athens, Greece;Head and Neck Research Group, Research Center, Akershus University Hospital, Lørenskog, Norway;Institute of Clinical Medicine, Campus Akershus University Hospital, University of Oslo, Nordbyhagen, Norway;Headache Center Seilerstaette, Department of Neurogeriatric medicine and Remobilisiation, Hospital Barmherzige Schwestern Linz, Linz, Austria;

关键词: Chronic migraine;    Refractory chronic migraine;    Disease progression;    rCM classification;   

DOI  :  10.1186/1129-2377-15-47

 received in 2014-07-15, accepted in 2014-07-29,  发布年份 2014

来源: Springer

【 摘 要 】

The debate on the clinical definition of refractory Chronic Migraine (rCM) is still far to be concluded. The importance to create a clinical framing of these rCM patients resides in the complete disability they show, in the high risk of serious adverse events from acute and preventative drugs and in the uncontrolled application of therapeutic techniques not yet validated.The European Headache Federation Expert Group on rCM presents hereby the updated definition criteria for this harmful subset of headache disorders. This attempt wants to be the first impulse towards the correct identification of these patients, the correct application of innovative therapeutic techniques and lastly aim to be acknowledged as clinical entity in the next definitive version of the International Classification of Headache Disorders 3 (ICHD-3 beta).

【 授权许可】

CC BY   
© Martelletti et al.; licensee Springer. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.